E-LIB Suche - Ergebnisse für: Paxton, Stuart S.

1

Becoming a Leader in Patient Satisfaction: Changing the Cul..:

Deitrick, Lynn M. ; Capuano, Terry A. ; Paxton, Stuart S....
Health Marketing Quarterly. 23 (2006) 3 - p. 31-57 , 2006

2

Characterisation of in-hospital complications associated wi..:

Drake, Thomas M ; Riad, Aya M ; Fairfield, Cameron J...
https://nottingham-repository.worktribe.com/output/5808335. , 2021

Link: https://doi.org/10.1016/..

3

Characterisation of in-hospital complications associated wi..:

Drake, TM ; Riad, AM ; Fairfield, CJ...
https://eprints.whiterose.ac.uk/176374/1/1-s2.0-S0140673621007996-main.pdf. , 2021

Link: https://eprints.whiteros..

4

Genomic and clinical characterization of early T-cell precu..:

Xu, Xinjie ; Paxton, Christian N. ; Hayashi, Robert J....
Blood Advances. 5 (2021) 14 - p. 2890-2900 , 2021

Link: https://doi.org/10.1182/..

5

UNITED STATES NAVY COUNTRY CURRENT: Havin' a Ball

Naxos Music Library Jazz

Nolan, Bob ; Martin, Glenn ; Kirby, Dave... ,

Link: http://suub.naxosmusicli..

6

Highly stable tetrathiafulvalene radical dimers in [3]caten..:

Spruell, Jason M ; Coskun, Ali ; Friedman, Douglas C...
https://doi.org/10.1038/nchem.749. , 2010

Link: https://doi.org/10.1038/..

7

Para-infectious brain injury in COVID-19 persists at follow..:

Michael, B.D ; Dunai, C ; Needham, E.J...
https://eprints.whiterose.ac.uk/209289/1/s41467-023-42320-4.pdf. , 2023

Link: https://eprints.whiteros..

8

Alternative pathway dysregulation in tissues drives sustain..:

Siggins, MK ; Davies, K ; Fellows, R...
https://discovery.ucl.ac.uk/id/eprint/10160844/1/Immunology%20-%202022%20-%20Siggins%20-%20Alternative%20pathway%20dysregulation%20in%20tissues%20drives%20sustained%20complement%20activation%20and.pdf. , 2023

Link: https://discovery.ucl.ac..

9

Quantifying neutralising antibody responses against SARS-Co..:

Roper, K.J ; Thomas, J ; Albalawi, W...
https://eprints.whiterose.ac.uk/205724/1/s41598-023-41928-2.pdf. , 2023

Link: https://eprints.whiteros..

10

SARS-CoV-2-specific nasal IgA wanes 9 months after hospital..:

Liew, F ; Talwar, S ; Cross, A...
eBioMedicine. , 2023

Link: https://bura.brunel.ac.u..

11

Para-infectious brain injury in COVID-19 persists at follow..:

Michael, BD ; Dunai, C ; Needham, EJ...
Nature Communications. , 2023

Link: http://bura.brunel.ac.uk..

12

SARS-CoV-2-specific nasal IgA wanes 9 months after hospital..:

Liew, F ; Talwar, S ; Cross, A...
https://eprints.whiterose.ac.uk/195314/1/PIIS2352396422005849.pdf. , 2023

Link: https://eprints.whiteros..

13

The P323L substitution in the SARS-CoV-2 polymerase (NSP12)..:

Goldswain, H ; Dong, X ; Penrice-Randal, R...
https://eprints.whiterose.ac.uk/198930/1/The%20P323L%20substitution%20in%20the%20SARS-CoV-2%20polymerase%20%28NSP12%29%20confers%20a%20selective%20advantage%20during%20infection.pdf. , 2023

Link: https://eprints.whiteros..

14

Distinct clinical symptom patterns in patients hospitalised..:

Millar, J.E ; Neyton, L ; Seth, S...
https://eprints.whiterose.ac.uk/207884/1/Distinct%20clinical%20symptom%20patterns%20in%20patients%20hospitalised%20with%20COVID-19%20in%20an%20analysis%20of%2059,011%20patients%20in%20the%20ISARIC-4C.pdf. , 2022

Link: https://eprints.whiteros..

15

Procalcitonin is not a reliable biomarker of bacterial coin..:

Relph, KA ; Russell, CD ; Fairfield, CJ...
https://eprints.whiterose.ac.uk/187366/1/ofac179.pdf. , 2022

Link: https://eprints.whiteros..